Aaron Gu, Esq. of Han Kun interviewed by International Pharmaceutical News for China on China's annual drug reporting system
July, 2022 - Shanghai, Mainland China
Aaron Gu, Esq. of Han Kun was recently invited by International Pharmaceutical News for China for a special interview on China's annual drug reporting system. The content of the interview was edited and published in the June 2022 issue of International Pharmaceutical News for China, entitled "In-depth Analysis of China's Annual Drug Reporting System".
Han Kun has a dedicated life sciences and healthcare team and has been consistently ranked as a leading law firm in the life sciences and healthcare sector by authoritative legal directories, such as Chambers and Partners, The Legal 500, Asialaw Profiles, and China Business Law Journal. The firm is committed to providing clients in the life sciences and healthcare industries with comprehensive legal services on all fronts, including private equity and venture capital, mergers and acquisitions, onshore and offshore capital markets, pharmaceutical license in/out and asset sale/purchase transactions, intellectual property, compliance and regulatory, data protection, and dispute resolution.
